The 6.5-month clinical study
Injection site reactions were the most common side effects of TAKHZYRO in the clinical study.
Most common side effects
TAKHZYRO
(84 people)*
(84 people)*
Placebo
(41 people)
(41 people)
Injection site reactions
- Pain
- Redness
- Bruising
52%
43%
10%
7%
34%
29%
2%
0%
Upper respiratory infection
29%
32%
Headache
21%
22%
Rash
7%
5%
Muscle pain
5%
0%
Dizziness
6%
0%
Diarrhea
5%
5%
*Included all people treated with TAKHZYRO (300 mg every 2 weeks, 300 mg every 4 weeks, or 150 mg every 4 weeks) in the clinical study.
The 2.5-year open-label extension study
The most common side effects seen in the long-term, open-label study were injection site reactions (including pain, redness, and bruising), upper respiratory infections, and headache.
Most common side effects
TAKHZYRO 300 mg every 2 weeks (212 people)
Injection site pain
47%
Viral upper respiratory tract infection
42%
Upper respiratory tract infection
26%
Headache
25%
Injection site redness
17%
Joint pain
13%
Injection site bruising
12%
Back pain
12%
Diarrhea
11%
Sinus infection
11%
Influenza
10%
Nausea
10%
Urinary tract infection
10%
All side effects in both studies occurred in ≥10% of people taking TAKHZYRO.